Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study (Q39342773)
Jump to navigation
Jump to search
scientific article published on 4 December 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study |
scientific article published on 4 December 2006 |
Statements
1 reference
Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study (English)
1 reference
Martin E Hale
1 reference
Harry Ahdieh
1 reference
Tina Ma
1 reference
Richard Rauck
1 reference
Oxymorphone ER Study Group 1
1 reference
4 December 2006
1 reference
1 reference
8
1 reference
2
1 reference
175-184
1 reference
Identifiers
1 reference
1 reference